Nancy Moore

494 total citations
13 papers, 128 citations indexed

About

Nancy Moore is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nancy Moore has authored 13 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nancy Moore's work include Sarcoma Diagnosis and Treatment (3 papers), Hemophilia Treatment and Research (3 papers) and Platelet Disorders and Treatments (2 papers). Nancy Moore is often cited by papers focused on Sarcoma Diagnosis and Treatment (3 papers), Hemophilia Treatment and Research (3 papers) and Platelet Disorders and Treatments (2 papers). Nancy Moore collaborates with scholars based in United States, Canada and Japan. Nancy Moore's co-authors include Sriram Krishnamoorthy, William E. Hobbs, Dipti Gupta, David R. Light, Robert Peters, Julia E. Brittain, Levi Makala, Betty S. Pace, Yaqin Li and Ivan J. Stone and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Nancy Moore

11 papers receiving 127 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Moore United States	6	47	44	43	40	27	13	128
Meghan Burke United States	4	51 1.1×	29 0.7×	37 0.9×	18 0.5×	13 0.5×	6	117
Kyriaki Manousou Greece	9	85 1.8×	26 0.6×	47 1.1×	65 1.6×	17 0.6×	31	153
Hélène Antoine‐Poirel Belgium	3	35 0.7×	52 1.2×	34 0.8×	37 0.9×	5 0.2×	3	127
Federico De Marchi United States	9	71 1.5×	41 0.9×	99 2.3×	46 1.1×	46 1.7×	14	193
Sandra Salazar United States	5	57 1.2×	36 0.8×	69 1.6×	18 0.5×	18 0.7×	10	163
Brett T. Brinker United States	5	65 1.4×	46 1.0×	37 0.9×	41 1.0×	23 0.9×	5	133
Bevan Tandon United States	5	47 1.0×	56 1.3×	43 1.0×	22 0.6×	12 0.4×	6	131
Foteini Kalofonou United Kingdom	7	24 0.5×	41 0.9×	17 0.4×	105 2.6×	70 2.6×	17	165
Evgeni Chubar Israel	7	69 1.5×	44 1.0×	95 2.2×	43 1.1×	9 0.3×	15	124
K R Reynolds United States	5	66 1.4×	72 1.6×	104 2.4×	11 0.3×	13 0.5×	10	190

Countries citing papers authored by Nancy Moore

Since Specialization

Citations

This map shows the geographic impact of Nancy Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Moore more than expected).

Fields of papers citing papers by Nancy Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Moore. The network helps show where Nancy Moore may publish in the future.

Co-authorship network of co-authors of Nancy Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Moore. A scholar is included among the top collaborators of Nancy Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Moore. Nancy Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Takebe, Naoko, Alice P. Chen, Shivaani Kummar, et al.. (2024). The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers. Cancer Chemotherapy and Pharmacology. 94(2). 157–167.

Salkeni, Mohamad A., Brian Ko, Brian A. Van Tine, et al.. (2023). A phase 2 study of an anti–PD-L1 antibody (atezolizumab) in dedifferentiated chondrosarcoma.. Journal of Clinical Oncology. 41(16_suppl). 11533–11533. 1 indexed citations

Salkeni, Mohamad A., Anthony P. Conley, Elizabeth J. Davis, et al.. (2022). A phase 2 study of anti-PD-L1 antibody (atezolizumab) in grade 2 and 3 chondrosarcoma.. Journal of Clinical Oncology. 40(16_suppl). 11528–11528. 2 indexed citations

Naqash, Abdul Rafeh, Geraldine O’Sullivan Coyne, Nancy Moore, et al.. (2021). Phase II study of atezolizumab in advanced alveolar soft part sarcoma (ASPS).. Journal of Clinical Oncology. 39(15_suppl). 11519–11519. 33 indexed citations

Gupta, Dipti, Samuel Lessard, Nancy Moore, et al.. (2019). Genetic Activation of NRF2 By KEAP1 Inhibition Induces Fetal Hemoglobin Expression and Triggers Anti-Oxidant Stress Response in Erythroid Cells. Blood. 134(Supplement_1). 210–210. 1 indexed citations

Takebe, Naoko, Geraldine O’Sullivan Coyne, Shivaani Kummar, et al.. (2018). Phase I trial of z-endoxifen with estrogen receptor imaging in adults with advanced hormone receptor–positive solid tumors including desmoid and gynecologic tumors.. Journal of Clinical Oncology. 36(15_suppl). 2516–2516.

Krishnamoorthy, Sriram, Betty S. Pace, Dipti Gupta, et al.. (2017). Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease. JCI Insight. 2(20). 36 indexed citations

Coyne, Geraldine O’Sullivan, Shivaani Kummar, Robert Meehan, et al.. (2017). Phase I study of indenoisoquinolines LMP776 in adults with relapsed solid tumors and lymphomas.. Journal of Clinical Oncology. 35(15_suppl). 2558–2558. 8 indexed citations

Krishnamoorthy, Sriram, Dipti Gupta, Nancy Moore, et al.. (2016). VLA‐4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow. British Journal of Haematology. 174(6). 970–982. 20 indexed citations

10.

Chen, Alice P., Mickey Williams, Shivaani Kummar, et al.. (2016). Feasibility of molecular profiling based assignment of cancer treatment (MPACT): A randomized NCI precision medicine study.. Journal of Clinical Oncology. 34(15_suppl). 2539–2539. 4 indexed citations

11.

Liu, Tongyao, Qi Lü, John D. Kulman, et al.. (2015). Enhanced Pharmacokinetics of Factor VIIa as a Monomeric Fc Fusion. Thrombosis Research. 135(5). 970–976. 11 indexed citations

12.

Aleman, Maria M., et al.. (2015). Platelet-Targeted rFVIIa-Xten Improves Thrombin Generation and Fibrin Formation Compared to Recombinant FVIIa. Blood. 126(23). 2269–2269. 3 indexed citations

13.

Chhabra, Ekta Seth, Nancy Moore, Amy M. Holthaus, et al.. (2015). Evaluation of Enhanced in Vitro Plasma Stability of a Novel Long Acting Recombinant FVIIIFc-VWF-XTEN Fusion Protein. Blood. 126(23). 2279–2279. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact